Advanced searches left 3/3

Cartilage Oligomeric Matrix Protein - ClinicalTrials.gov

Summarized by Plex Scholar
Last Updated: 12 October 2021

* If you want to update the article please login/register

The Level of Cartilage Oligomeric Matrix Protein (COMP) and Urinary C-Terminal Telopeptides of Type II Collagen (uCTX-II) After Prolotherapy Intervention and The Functional Outcome in Patient With Knee Osteoarthritis

Layout: \ n \ nDouble-blind randomized trial \ n \ nRandomization: \ n \ nSimple Randomization generated by an on-line randomizer \ n \ nSample Size: \ n \ nDifference between two ways of main outcome where \ n \ nmean distinction = 0. 05 \ npool difference = 0. 09 \ nZ 1-α/ 2 = 1. 95 with type 1 mistake 5% \ n1-β = 1. 282 with power 90%.

Source link: https://clinicaltrials.gov/ct2/show/NCT04557943

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions